3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34386061 | Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression. | 2021 Sep | 2 |
2 | 34907286 | Uncovering drug repurposing candidates for head and neck cancers: insights from systematic pharmacogenomics data analysis. | 2021 Dec 14 | 1 |
3 | 32375124 | Exosomal long non-coding RNA MSTRG.292666.16 is associated with osimertinib (AZD9291) resistance in non-small cell lung cancer. | 2020 May 6 | 2 |